TTUHSC Center for Translational Neuroscience and Therapeutics
HomeCenter for Translational Neuroscience and Therapeutics

Seed Funds

The Center of Excellence for Translational Neuroscience and Therapeutics (CTNT) is accepting applications for seed funds. If interested, please, send Dr. Volker Neugebauer a Letter of Intent with a one page description of the proposed project including novelty and significance, overall hypothesis, specific aims and proposed experiments/studies. 

This information will be distributed to CTNT members in advance of your informal chalk talk presentation of the project. 

 

Scope and requirements:

 Topic: Translational research, defined broadly as research addressing a clinically relevant "condition", intervention or target.  Research itself can be basic science and does not need to be "clinical".

 Goal: To generate preliminary data and grant applications for external funding by the end of the seed fund period.  A viable  plan for obtains external funding, including a grant application by the end of the seed grant, is required.

 Investigator(s): Team of CTNT members from basic science and clinical departments; additional Investigators and  Consultants can be included.

 Budget request: 1 year, $30k maximum (as justified)

   ***Click here to further view Seed Fund guidelines and key points.    

 

Awardees

2015

  • Yoon, Y, PhD (PI), Wilms, H, MD, and Neugebauer, V, MD, PhD.
    Auditory Cortex Implant - Neural responses at primary auditory cortex in response to spectral and temporal signals processed by speech processor
  • Reddy, A, PhD (PI), Lawrence, JJ, PhD, DeToledo, J, MD.
    Protective effects of selective serotonin reuptake inhibitor, Citalopram, against Alzheimer's Disease

2016

  • Jansen, M, PhD (PI), Dissanaike, S, MD (Co-PI).
    nAChR-alpha7 and RIC-3 expressions in sepsis and modulation by nicotine
  • Ganapathy, V., PhD (PI), Lawrence, JJ, PhD (Co-PI), Neugebauer, V, MD, PhD (Co-PI), DeToledo, J, MD.
    Characterization of the humanized mouse for SLC13A5, a transporter whose loss of function causes neonatal epilepsy and encephalopathy

2017

  • Karamyshev, A, PhD (PI), Reddy, H, PhD, Wilms, H, MD, DeToledo, J, MD.
    Development of Technology to Identify Markers for Early Detection of Neurodegenerative Diseases




                      

 

 

 

 

 

 

©